prostate-report.org

Treatment of prostate cancer increases bone loss

Evaluating data from bisphosphonate treatment of cancer patients receiving chemotherapy, the researchers found those who received bisphosphonate treatment and androgen deprivation therapy did show an increase in bone loss.

This information is not only a concern for the specialists, but also for the general practitioners who frequently encounter these patients.”

The study has been published in the online edition of the American Society of Clinical Oncology.